From Bethesda Magazine: 20/20 BioLabs CEO on the Gaithersburg biotech’s February stock market debut
The company is aiming for Medicare coverage for its suite of at-home screening products for cancers and other illnesses The post From Bethesda Magazine: 20/20 BioLabs CEO on the Gaithersburg biotech’s February stock market debut appeared first on Bethesda Magazine .
Read this story on bethesda-magazine